Literature DB >> 4395502

An analysis of the coronary vascular responses to catecholamines, using a modified Langendorff heart preparation.

K J Broadley.   

Abstract

1. A modified Langendorff heart preparation from the guinea-pig was used to analyse catecholamine responses. Contractile force, heart rate and coronary perfusion pressure were recorded.2. Four components of the vascular response could be identified.(a) The initial phase was a vasoconstriction mediated by alpha-adrenoceptors which preceded any effects on heart rate and force.(b) A secondary constriction followed, which was due to the increased myocardial compression during positive inotropic and chronotropic responses.(c) The third, more predominant, effect was a prolonged dilatation probably associated with the increased metabolic activity of the heart.(d) A fourth component was a direct vasodilatation mediated by beta-adrenoceptors which was evident when small doses of catecholamines were used but was usually masked by the more pronounced metabolically linked dilatation.3. The actions of salbutamol were examined and since it caused direct vasodilatation by stimulation of beta-adrenoceptors without other myocardial effects, these adrenoceptors were classified as the beta(2)-type.4. I.C.I. 50,172 was employed to block selectively the myocardial effects due to stimulation of beta(1)-adrenoceptors and leave the vasodilator beta(2)-adrenoceptors unaffected.5. Adrenaline, noradrenaline and isoprenaline were compared at two dose levels, in the presence or absence of effects on heart rate and force.6. Constrictor or dilator effects were found in the absence of other effects and were shown to depend to some extent on the rate of coronary perfusion.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4395502      PMCID: PMC1702910          DOI: 10.1111/j.1476-5381.1970.tb10642.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

1.  AN INTRINSIC ADRENERGIC VASODILATOR MECHANISM IN THE CORONARY VASCULAR BED OF THE DOG.

Authors:  F J KLOCKE; G A KAISER; J ROSS; E BRAUNWALD
Journal:  Circ Res       Date:  1965-04       Impact factor: 17.367

2.  RESPONSES OF CORONARY SMOOTH MUSCLE TO CATECHOLAMINES.

Authors:  R C ZUBERBUHLER; D F BOHR
Journal:  Circ Res       Date:  1965-05       Impact factor: 17.367

3.  Influence of cardiac activity on coronary flow control.

Authors:  R C DOUGLAS; V ARMENGOL; J TALESNIK
Journal:  Acta Physiol Lat Am       Date:  1960

4.  Effect of cardiac contraction on coronary blood flow.

Authors:  D E GREGG; D C SABISTON
Journal:  Circulation       Date:  1957-01       Impact factor: 29.690

5.  Effects of epinephrine, nor-epinephrine and khellin on circulation through isolated perfused hearts.

Authors:  I R Leusen; H E Essex
Journal:  Am J Physiol       Date:  1953-01

6.  The coronary circulation: II. The effect of changes of temperature and of heart rate.

Authors:  G V Anrep; H Häusler
Journal:  J Physiol       Date:  1929-06-07       Impact factor: 5.182

7.  [Studies on coronary circulation. II. Action of the vagus and sympathetic nerves].

Authors:  J GARCIA RAMOS; J ALANIS; J LUCO
Journal:  Arch Inst Cardiol Mex       Date:  1950-08-31

8.  Effect of epinephrine, aminophylline, nitroglycerine and papaverine on coronary inflow and on heart contraction, as recorded concurrently.

Authors:  K I MELVILLE; F C LU
Journal:  J Pharmacol Exp Ther       Date:  1950-07       Impact factor: 4.030

9.  Selective blockade of adrenoceptive beta receptors in the heart.

Authors:  D Dunlop; R G Shanks
Journal:  Br J Pharmacol Chemother       Date:  1968-01

10.  Salbutamol: a new, selective beta-adrenoceptive receptor stimulant.

Authors:  V A Cullum; J B Farmer; D Jack; G P Levy
Journal:  Br J Pharmacol       Date:  1969-01       Impact factor: 8.739

View more
  12 in total

1.  Proceedings: A procedure to demonstrate the release of a vasoactive metabolite by catecholamines from perfused guinea-pig hearts.

Authors:  K J Broadley
Journal:  Br J Pharmacol       Date:  1975-06       Impact factor: 8.739

2.  Contractile properties of hypertrophied and normal rat hearts [proceedings].

Authors:  R A Brown; A M Solca
Journal:  Br J Pharmacol       Date:  1976-07       Impact factor: 8.739

3.  Negative inotropic responses of the isolated heart of the rat to isoprenaline.

Authors:  K J Broadley
Journal:  Br J Pharmacol       Date:  1972-05       Impact factor: 8.739

4.  The evidence for alpha-adrenoceptors in the coronary circulation and their possible relevance to the physiological regulation of myocardial blood flow.

Authors:  J R Parratt
Journal:  Basic Res Cardiol       Date:  1981 Sep-Oct       Impact factor: 17.165

Review 5.  The continuing evolution of the Langendorff and ejecting murine heart: new advances in cardiac phenotyping.

Authors:  Ronglih Liao; Bruno K Podesser; Chee Chew Lim
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-05-25       Impact factor: 4.733

6.  The effects of dipyridamole on the myocardial vasodilator actions of noradrenaline, isoprenaline and adenosine.

Authors:  J R Parratt; R M Wadsworth
Journal:  Br J Pharmacol       Date:  1972-12       Impact factor: 8.739

7.  The role of H1 and H2-receptors in the coronary vascular response to histamine of isolated perfused hearts of guinea-pigs and rabbits.

Authors:  K J Broadley
Journal:  Br J Pharmacol       Date:  1975-08       Impact factor: 8.739

8.  The release of a coronary vasodilator metabolite from the guinea-pig isolated perfused heart stimulated by catecholamines, histamine and electrical pacing and by exposure to anoxia.

Authors:  K J Broadley
Journal:  Br J Pharmacol       Date:  1976-09       Impact factor: 8.739

9.  Characterization of the coronary vascular -adrenoceptor in the pig.

Authors:  G M Drew; G P Levy
Journal:  Br J Pharmacol       Date:  1972-10       Impact factor: 8.739

10.  Local myocardial perfusion and epicardial NADH-fluorescence after coronary artery ligation in the isolated guinea pig heart.

Authors:  R Rösen; A Marsen; W Klaus
Journal:  Basic Res Cardiol       Date:  1984 Jan-Feb       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.